JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 5 No. 11 828-839
© 1964 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, E. M.
Right arrow Articles by Wagner, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, E. M.
Right arrow Articles by Wagner, H. N., Jr.

Determination of Protein-Bound Iodine (PBI) In Human Plasma by Thermal Neutron Activation Analysis2

Edward M. Smith, James M. Mozley and Henry N. Wagner, Jr.1

Baltimore

ABSTRACT

Neutron activation analysis was found to be a precise method for measuring PBI in plasma. Passage of human plasma through ion exchange resins in the ammonium acetate form prior to neutron activation removed greater than 99.9 per cent of the inorganic iodide as well as most other inorganic ions. Neutron bombardment of the treated plasma in a nuclear reactor with a flux density of approximately 1011 thermal neutrons/cm2 sec activated I127 to the radioactive isotope I28. After irradiation, major radiochemical impurities were eliminated by simple radiochemical technique (stable isotope dilution and differential precipitation). The induced I128 radioactivity was measured and compared to activated iodide standard by gamma-ray spectrometry using spectrum stripping to eliminate interference from remaining radioactive contaminants. The activation analysis technique yielded results which were systematically 1.8 µg/100 ml higher than the Barker chemical method although thyroxine recovery studies run on both procedures were identical. This systematic difference could not be attributed to any systematic error in the activation analysis procedure indicating this technique may be measuring an additional iodine component of plasma such as iodotyrosines. Advantages over chemical methods of measuring PBI are elimination of the protein digesting step, elimination of the reagent blank and a reduction in the problem of iodine contamination.

FOOTNOTES

2 This project was supported in part by USPHS Research Grant No. A-6155.

1 The Johns Hopkins Medical Institutions.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1964 by the Society of Nuclear Medicine.